Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Honesty, Of A Sort | Main | In Hoc Signo Non Vinces »

January 20, 2010

A Database of Side Effects

Email This Entry

Posted by Derek

There's probably a lot of undiscovered information sitting out there in clinical trial data sets. And while I was just worrying the other day about people with no statistical background digging through such things, I have to give equal time to the flip side: having many different competent observers taking a crack at these numbers would, in fact, be a good thing.

Here's one effort of that sort, as detailed in Molecular Systems Biology. The authors have set up a database of all the side-effect information released through package inserts of approved drugs, which was much more of a pain than it sounds like, since the format of this information isn't standardized.

Looking over their data, the drugs with the highest number of side effects are the central nervous system agents, which makes sense. Many of these are polypharmacological; I'm almost surprised they aren't even worse by a wider margin. Antiparasitics have the fewest side effects (possibly because some of these don't even have to be absorbed?), followed by "systemic hormonal preparations". To be fair, the CNS category has the largest number of drugs in it, and those other two have the least, so this may be just a sampling problem. At a glance, one category that seems to have a disproportionate number of side effects, compared its number of approved drugs, is the "genitourinary/sex hormone" class, with muskoskeletal agents also making a stronger showing than their numbers might indicate.

Comments (15) + TrackBacks (0) | Category: Clinical Trials | Toxicology


COMMENTS

1. PharmaHeretic on January 20, 2010 11:01 AM writes...

In previous ages "side effects" were developed into new drugs.. now MBAs and lawyers make sure that it does not happen (admitting liability).

Consider that anti-pyschotics, tricyclic antidepressants and the first synthetic anticholinergics were developed from the antihistamine pharmacophore, as was the accidental discovery of synthetic opioids. Mustard gas led to
Mechlorethamine. Heck even the cytotoxic effects of radiation were discovered as a "side effect"

The adverse effects of anti-bacterial sulfonamides led to carbonic anhydrase inhibitors and sulfonylureas.

The use of PDE5 inhibitors for ED and the usable immunosupressive effects of low dose anti-cancer nucleotides were also a new use of "side effects"

Permalink to Comment

2. Strauss Wagner on January 20, 2010 11:39 AM writes...

Exactly, what we must avoid is that television is not a negative influence on our children as they rely on the attitude and performance of individuals who are on television, there are many cases like the House that by their addiction vicodin has led to people using this medication and this is proven in the U.S., since 40% of the American population is assiduous to this medicine and is caused by the influence that Dr. House at the time, as indicated findrxonline in his article that this medicine is dangerous if not properly due to moderation.
Hopefully, the media are aware that an important means of educating future generations.

Permalink to Comment

3. anonymous on January 20, 2010 12:12 PM writes...

How exactly posts like #2 struuss wagner are generated ? Must be some software running through blogs related to medecine/drugs etc. and composing some random sentences which incorporate a key name of the medication. But what is the purpose of this activity ? does it really work and promote stuff ?

Permalink to Comment

4. SP on January 20, 2010 12:34 PM writes...

Reading such gibberish gives you such a painful headache that you want some Vicodin.
Almost every HTS we've run has at least one tricyclic antidepressant come up as a primary screening hit.

Permalink to Comment

5. Cloud on January 20, 2010 12:41 PM writes...

anonymous #3- I'd guess that the purpose of those semi-coherent machine generated posts is not to fool human readers, but to fool other software. Modern search engine algorithms use links to a web page page to help determine how high up in the search results it is displayed. They also look at the context of the link.

Permalink to Comment

6. David on January 20, 2010 1:26 PM writes...

I'd guess that CNS drugs have the highest number of Adverse Effects (the correct term) partly because we have a diverse experience of brain function. If function is disrupted in different parts, we get different effects. In contrast, for example, if you get ischemia anywhere in the heart, you get pain. The number of terms we have to describe brain-related disorders is much greater, reflecting that we are "CNS splitters" and "everything else lumpers."

It is grossly unjustified to compare AEs accross studies of different designs, in different populations, and in different sociologic contexts.

Permalink to Comment

7. barry on January 20, 2010 1:49 PM writes...

one of the other great stories of an "adverse effect" exploited is cyclosporin-A, first found in an anti-fungal screen. Not as profitable as sildenafil, but perhaps more important in the grand scheme of healthcare.

Permalink to Comment

8. Anonymous on January 20, 2010 1:51 PM writes...

#3 - These things remind me of that automatic computer science paper generator thats been running around for a while now. Step 1) Pick random prases with big words step 2) string'em together and hope for the best.

Permalink to Comment

9. darwin on January 20, 2010 2:55 PM writes...

Rough day today. I think I will open my desk drawer for a jigger of side effect.

Permalink to Comment

10. CMCguy on January 20, 2010 3:36 PM writes...

RE statement "much more of a pain than it sounds like, since the format of this information isn't standardized." I would take observation a step further because often terms and definitions can not be precise/identical at different companies/departments and even within FDA/individual reviewers. I have seen MDs argue about AEs but (to me at least) was all about semantics not substance. I know there are many guidelines for Clinical Trials reporting however such conventions appear to get scrambled in label claims after others groups have their say.

Permalink to Comment

11. biobug on January 20, 2010 4:14 PM writes...

Quick comment on the database, after a short look it appears they don't capture any black box data, and are missing some other things... Probably better to have no database and just stick to checking labels.

Permalink to Comment

12. Late Fred on January 20, 2010 5:06 PM writes...

anonymous (#3), those posts are not intended to fool people. Their purpose is just to generate a lot of hyperlinks from reputable sites to their sales one. Google's index considers sites "better" when they are linked from a lot of places, so the idea is that the sales site will move higher in the Google rankings and improve its sales that way.

This doesn't work very well, for a few reasons. One is that Google's crawler is slowly getting better at detecting and ignoring comment spam. Another is that humans are so good at noticing and deleting it before it ever has any effect on the rankings.

If you want details on how the text is built, do a web search for: Markov text generator

Permalink to Comment

13. Vittorio Montanari on January 20, 2010 6:54 PM writes...

There is a post by Google's Director of Research on the nature of "effects" on his site
http://norvig.com/experiment-design.html

Permalink to Comment

14. befuddled on January 21, 2010 9:00 AM writes...

Surprising. I had always thought of the antiparasitics as pretty nasty drugs as a class.

Permalink to Comment

15. PeterC on January 21, 2010 1:07 PM writes...

I'd say one of the reasons antiparasitics aren't that harmful is that they are ment to bind pathogen protein.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
The Palbociclib Saga: Or Why We Need a Lot of Drug Companies
Why Not Bromine?
Fragonomics, Eh?
Amicus Fights Its Way Through in Fabry's
Did Pfizer Cut Back Some of Its Best Compounds?
Don't Optimize Your Plasma Protein Binding
Fluorinated Fingerprinting
One of Those Days